Epocrates, Inc. (EPOC) Reports In-Line Q2 EPS of 7c; Cuts FY11 Sales Guidance
Tweet
Share
E-mailGet Alerts EPOC Hot Sheet
Join SI Premium – FREE
Epocrates, Inc. (NASDAQ: EPOC) reported Q2 EPS of $0.07, in-line with the analyst estimate of $0.07. Revenue for the quarter came in at $27.9 million versus the consensus estimate of $29.59 million.
Sees FY2011 EPS of $0.01-$0.10, versus the consensus of $0.09. Sees FY2011 revenue of $115-$120 million, versus prior guidance of $122-$125 million and the consensus of $123 million.
Sees FY2011 EPS of $0.01-$0.10, versus the consensus of $0.09. Sees FY2011 revenue of $115-$120 million, versus prior guidance of $122-$125 million and the consensus of $123 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Beyond Air, Inc. (XAIR) Tops Q1 reported Q1 Revenue ; Offers Guidance
- Paysafe Limited (PSFE) Misses Q2 EPS by 43c; offers guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
